Paysign Community

NasdaqCM:PAYS Community

1 Narratives written by author
0 Comments on narratives written by author
20 Fair Values set on narratives written by author

AN

AnalystConsensusTarget

Consensus Narrative from 5 Analysts

Patient Affordability And SaaS Entry Will Promise Success With Risks

Key Takeaways Acquisition of Gamma Innovation LLC expands Paysign into high-margin SaaS market, boosting potential revenue through integrated plasma and pharmaceutical solutions. Strong patient affordability segment growth, debt-free status, and cash reserves position Paysign well for future opportunities and market stability.

US$6.05

FV

63.8% undervalued

15.65%

Revenue growth p.a.

0

0

12

Updated